Search research articles
Contact Us
Filters
Showing results (151-160 of 167) with videos related to
Page
of 17
Sort By:
European Heart Journal
|
February 25, 2005
Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity
K Malmberg, L Rydén, H Wedel, et al.
International Journal of Cardiology. Heart & Vasculature
|
October 19, 2020
Incidence of acute myocardial infarction-related cardiogenic shock during corona virus disease 19 (COVID-19) pandemic
M D Lauridsen, J H Butt, L Østergaard, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
March 23, 2017
Gender differences in the effects of cardiovascular drugs
J Tamargo, G Rosano, T Walther, et al.
Diabetes, Obesity & Metabolism
|
September 18, 2009
Weight and blood pressure response to weight management and sibutramine in diabetic and non-diabetic high-risk patients: an analysis from the 6-week lead-in period of the sibutramine cardiovascular outcomes (SCOUT) trial
L F Van Gaal, I D Caterson, W Coutinho, et al.
Diabetologia
|
May 11, 2010
Changes in short- and long-term cardiovascular risk of incident diabetes and incident myocardial infarction--a nationwide study
M L Norgaard, S S Andersen, T K Schramm, et al.
Public Health
|
January 17, 2022
Return to work after COVID-19 infection - A Danish nationwide registry study
P A Jacobsen, M P Andersen, G Gislason, et al.
American Heart Journal Plus : Cardiology Research and Practice
|
March 21, 2024
One-year incidence of depression, anxiety, or stress disorders following a first-time heart failure diagnosis: A Danish nationwide registry-based study
M W Pedersen, R Rørth, M P Andersen, et al.
Diabetologia
|
September 15, 2010
Metformin treatment is associated with a low risk of mortality in diabetic patients with heart failure: a retrospective nationwide cohort study
C Andersson, J B Olesen, P R Hansen, et al.
International Journal of Obesity (2005)
|
December 19, 2014
Changes in body weight and pulse: outcome events in overweight and obese subjects with cardiovascular disease in the SCOUT trial
R V Seimon, D Espinoza, N Finer, et al.
Journal of Internal Medicine
|
January 15, 2009
Clinical consequences of hospital variation in use of oral anticoagulant therapy after first-time admission for atrial fibrillation
M L Hansen, N Gadsbøll, S Rasmussen, et al.
Page
of 17
Search research articles
Search
Showing results (151-160 of 167) with videos related to
Sort By:
Page
of 17
European Heart Journal
|
February 25, 2005
Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity
K Malmberg, L Rydén, H Wedel, et al.
International Journal of Cardiology. Heart & Vasculature
|
October 19, 2020
Incidence of acute myocardial infarction-related cardiogenic shock during corona virus disease 19 (COVID-19) pandemic
M D Lauridsen, J H Butt, L Østergaard, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
March 23, 2017
Gender differences in the effects of cardiovascular drugs
J Tamargo, G Rosano, T Walther, et al.
Diabetes, Obesity & Metabolism
|
September 18, 2009
Weight and blood pressure response to weight management and sibutramine in diabetic and non-diabetic high-risk patients: an analysis from the 6-week lead-in period of the sibutramine cardiovascular outcomes (SCOUT) trial
L F Van Gaal, I D Caterson, W Coutinho, et al.
Diabetologia
|
May 11, 2010
Changes in short- and long-term cardiovascular risk of incident diabetes and incident myocardial infarction--a nationwide study
M L Norgaard, S S Andersen, T K Schramm, et al.
Public Health
|
January 17, 2022
Return to work after COVID-19 infection - A Danish nationwide registry study
P A Jacobsen, M P Andersen, G Gislason, et al.
American Heart Journal Plus : Cardiology Research and Practice
|
March 21, 2024
One-year incidence of depression, anxiety, or stress disorders following a first-time heart failure diagnosis: A Danish nationwide registry-based study
M W Pedersen, R Rørth, M P Andersen, et al.
Diabetologia
|
September 15, 2010
Metformin treatment is associated with a low risk of mortality in diabetic patients with heart failure: a retrospective nationwide cohort study
C Andersson, J B Olesen, P R Hansen, et al.
International Journal of Obesity (2005)
|
December 19, 2014
Changes in body weight and pulse: outcome events in overweight and obese subjects with cardiovascular disease in the SCOUT trial
R V Seimon, D Espinoza, N Finer, et al.
Journal of Internal Medicine
|
January 15, 2009
Clinical consequences of hospital variation in use of oral anticoagulant therapy after first-time admission for atrial fibrillation
M L Hansen, N Gadsbøll, S Rasmussen, et al.
Page
of 17